PeptidePedia The community reference

Guangzhou JEEP Biotechnology (revision 10)

Old revision·22:04, 10 Aug 2024·VerifyVesna

This is an old revision of this page, as it stood at 22:04, 10 Aug 2024, saved by VerifyVesna with the summary replace primary source with the review. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Guangzhou JEEP Biotechnology Co., Ltd.
Legal nameGuangzhou JEEP Biotechnology Co., Ltd.
Trading nameJEEP
Other designationsJEEP Peptides, JEEP Bio
Organisation infobox · conventions

Guangzhou JEEP Biotechnology Co., Ltd. (trading as JEEP; jeepbio.com) is a research-peptide manufacturer based in Guangzhou, Guangdong, China, trading as JEEP Peptides, with a catalogue concentrated on incretin analogues and a substantial associated third-party testing record.[1][2]

The organisation is one of twenty covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]

Corporate identity and history

[edit]

The organisation operates from Guangzhou, in the Pearl River Delta.[1] No incorporation year is documented in sources available to this wiki and none is asserted here.

Its distinguishing feature among the entities covered on this wiki is specialisation: where most catalogues span peptides, SARMs, oils and bulk raw materials in roughly equal measure, this one is weighted heavily towards incretin analogues.[2] A narrower catalogue is not in itself better, but it does mean that the associated report set is concentrated on a small number of analytes, which makes the set more internally comparable than a set spread thinly across a hundred products.[4]

The trading name coincides with a well-known motor-vehicle marque. No relationship exists or is implied, and the coincidence is recorded only because it makes searching for the organisation unusually difficult.

References

  1. ^ a b National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
  2. ^ a b Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
  3. ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
  4. ^ Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.